Protek Group increased its H1 net profit under IFRS by 5.6% year-on-year to RUB 1.29 billion from RUB 1.221 billion, the company reported.
Revenue grew by 17% to RUB 66.579 billion from RUB 56.844 billion, pre-tax profit by 6% to RUB 1.62 billion from RUB 1.527 billion. Operating profit decreased by 4.3% to RUB 1.4 billion from RUB 1.463 billion.
Protek Group (tax number: 7715354473) is a Russian pharmaceuticals distributor. The group's key companies in various segments are: national distributor of pharmaceuticals and healthcare & beauty products CJSC Tsentr Vnedreniya Protek (English: CV Protek), network of pharmacies Rigla and pharmaceutical manufacturer FarmFirma Sotex.
IFRS net profit of Protek Group for 2012 grew 1.5-fold to RUB 2.8 billion from RUB 1.8 billion in 2011. Revenue increased by 17.2% to RUB 125.502 billion from RUB 107.052 billion, pre-tax profit by 51% to RUB 3.586 billion from RUB 2.375 billion.